OCS
Price
$8.09
Change
+$0.22 (+2.80%)
Updated
Oct 22 closing price
Capitalization
449.22M
18 days until earnings call
Intraday BUY SELL Signals
ONCO
Price
$0.41
Change
-$0.03 (-6.82%)
Updated
Oct 22 closing price
Capitalization
1.78M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OCS vs ONCO

OCS vs ONCO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
OCS vs. ONCO commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCS is a StrongBuy and ONCO is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for OCS with price predictions
Oct 22, 2026

OCS's RSI Oscillator ascending out of oversold territory

The RSI Indicator for OCS moved out of oversold territory on October 21, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 19 of the 22 cases the stock moved higher. This puts the odds of a move higher at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 33 of 48 cases where OCS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.

The Moving Average Convergence Divergence (MACD) for OCS just turned positive on October 21, 2026. Looking at past instances where OCS's MACD turned positive, the stock continued to rise in 33 of 49 cases over the following month. The odds of a continued upward trend are 67%.

Following a +8.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where OCS advanced for three days, in 151 of 201 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

OCS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

The Aroon Indicator for OCS entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.048) is normal, around the industry mean (2.973). P/E Ratio (-5.862) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. OCS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for ONCO with price predictions
Oct 22, 2026

Momentum Indicator for ONCO turns negative, indicating new downward trend

ONCO saw its Momentum Indicator move below the 0 level on October 06, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned negative. In 73 of the 77 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ONCO turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 31 similar instances when the indicator turned negative. In 30 of the 31 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

ONCO moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ONCO crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONCO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for ONCO's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +21.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where ONCO advanced for three days, in 132 of 161 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

ONCO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.132) is normal, around the industry mean (2.973). P/E Ratio (0.001) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.598) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. ONCO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONCO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
OCSONCO
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 25 days ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
64%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
55%
N/A
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (OCS: $7.87 vs. ONCO: $0.44)
Brand notoriety: OCS and ONCO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCS: 139% vs. ONCO: 22%
Market capitalization -- OCS: $449.22M vs. ONCO: $1.78M
OCS [@Biotechnology] is valued at $449.22M. ONCO’s [@Biotechnology] market capitalization is $1.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCS’s FA Score shows that 2 FA rating(s) are green while ONCO’s FA Score has 0 green FA rating(s).

  • OCS’s FA Score: 2 green, 3 red.
  • ONCO’s FA Score: 0 green, 5 red.
According to our system of comparison, OCS is a better buy in the long-term than ONCO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCS’s TA Score shows that 4 TA indicator(s) are bullish while ONCO’s TA Score has 4 bullish TA indicator(s).

  • OCS’s TA Score: 4 bullish, 2 bearish.
  • ONCO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, OCS is a better buy in the short-term than ONCO.

Price Growth

OCS (@Biotechnology) experienced а +9.76% price change this week, while ONCO (@Biotechnology) price change was -20.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

OCS is expected to report earnings on Nov 09, 2026.

ONCO is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
OCS
Daily Signal:
Gain/Loss:
ONCO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with PRAX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then PRAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
+2.80%
PRAX - OCS
33%
Loosely correlated
+0.96%
JSPR - OCS
33%
Poorly correlated
-1.73%
FTH - OCS
32%
Poorly correlated
-2.28%
IMNM - OCS
30%
Poorly correlated
+1.44%
JBIO - OCS
30%
Poorly correlated
-1.45%
More

ONCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCO has been loosely correlated with PCSA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCO jumps, then PCSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCO
1D Price
Change %
ONCO100%
-6.53%
PCSA - ONCO
35%
Loosely correlated
+5.68%
NIKI - ONCO
28%
Poorly correlated
-0.53%
NBTX - ONCO
25%
Poorly correlated
+13.01%
OCS - ONCO
25%
Poorly correlated
+2.80%
TBPH - ONCO
24%
Poorly correlated
N/A
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FDS335.4515.54
+4.86%
Factset Research Systems
CZNC26.641.01
+3.94%
Citizens & Northern Corp
NCI0.720.03
+3.65%
Neo-Concept International Group Holdings Limited
CNXN88.510.78
+0.89%
PC Connection
UPXI0.80-0.07
-7.98%
Upexi Inc